24
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
mifepristone
Rosenfeld Cancer Center at Abington Memorial Hospital, Abington
Bryn Mawr Hospital, Bryn Mawr
Lankenau Cancer Center at Lankenau Hospital, Wynnewood
Regional Cancer Center at Singing River Hospital, Pascagoula
Lake/University Ireland Cancer Center, Mentor
Marshfield Clinic - Marshfield Center, Marshfield
Hinsdale Hematology Oncology Associates, Hinsdale
Freeman Cancer Institute at Freeman Health System, Joplin
Hulston Cancer Center at Cox Medical Center South, Springfield
Methodist Estabrook Cancer Center, Omaha
Woman's Hospital, Baton Rouge
Oklahoma University Cancer Institute, Oklahoma City
Kaiser Permanente Medical Center - Los Angeles, Los Angeles
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain
Maine Medical Center - Bramhall Campus, Portland
Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township
Case Comprehensive Cancer Center, Cleveland
Riverside Methodist Hospital Cancer Care, Columbus
Cancer Center of Paoli Memorial Hospital, Paoli
Women and Infants Hospital of Rhode Island, Providence
University of Texas Medical Branch, Galveston
Gynecologic Oncology Group
NETWORK